Allergy Therapeutics (AGY)

 

Latest News

All resolutions passed at AGM of Allergy Therapeutics

Allergy Therapeutics has announced that all resolutions were passed by shareholders at today's Annual General Meeting. A...

Result of AGM

RNS Number: 2447X Allergy Therapeutics PLC 22 November 2017 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Group") Result of Annual General Meeting 22 November 2017 Allergy Therapeutics plc (AIM:AGY), the fully integrated specialty pharmaceutical group specialising in allergy vaccines, announces that, at its Annual General Meeting held this m...

Block Listing Application

RNS Number: 0383X Allergy Therapeutics PLC 21 November 2017 21 November 2017 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company") Block Listing Application Allergy Therapeutics (AIM:AGY) , the fully integrated specialty pharmaceutical company specialising in allergy vaccines, announces that an application has been made to the London Stoc...

Allergy Therapeutics to Present at Jefferies 2017

RNS Number: 2495W Allergy Therapeutics PLC 13 November 2017 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Group") Allergy Therapeutics to Present at Jefferies 2017 London Healthcare Conference 13 November 2017 Allergy Therapeutics plc (AIM:AGY), the fully integrated specialty pharmaceutical group specialising in allergy vaccines, announces th...

All News

DateHeadlineSource
01-04-15Holding(s) in CompanyRNS
30-03-15Result of General Meeting and Issue of EquityRNS
10-03-15Allergy Therapeutics placing raises £20m StockMarketWire
10-03-15Issue of EquityRNS
02-03-15Allergy Therapeutics revenues up StockMarketWire
02-03-15Half Yearly ReportRNS
30-01-15Holding(s) in CompanyRNS
12-01-15Allergy Therapeutics revenues up 11%StockMarketWire
12-01-15Trading UpdateRNS
16-12-14Allergy Therapeutics appoints adviser StockMarketWire
16-12-14Change of AdviserRNS
19-11-14Allergy Therapeutics resolutions passed at AGMStockMarketWire
19-11-14Result of AGMRNS
18-11-14Allergy strengthens its board StockMarketWire
18-11-14Appointment of a Non-Executive DirectorRNS
05-11-14Grant of OptionsRNS
04-11-14Appointment of Head of Clinical ScienceRNS
23-10-14Annual Report and AccountsRNS
08-10-14Allergy Therapeutics director steps down StockMarketWire
08-10-14Directorate ChangeRNS
01-10-14Total Voting RightsRNS
30-09-14Amendment of 2012 Loan Note termRNS
29-09-14Holding(s) in CompanyRNS
24-09-14Exercise of OptionsRNS
24-09-14Annual Report and AccountsRNS
22-09-14Profits improve at Allergy TherapeuticsStockMarketWire
22-09-14Final ResultsRNS
04-09-14Shareholder updateRNS
27-08-14Allergy Therapeutics schedules results announcementStockMarketWire
24-07-14Allergy Therapeutics revenues upStockMarketWire
24-07-14Notice of Results and Trading UpdateRNS
17-07-14Holding(s) in CompanyRNS
30-04-14Allergy Therapeutics' licence renewedStockMarketWire
30-04-14Worthing Facility Licence RenewalRNS
25-04-14Director/PDMR ShareholdingRNS
17-04-14Allergy Therapeutics convertible loan extendedStockMarketWire
17-04-14Extension of Convertible Loan NoteRNS
02-04-14Holding(s) in CompanyRNS
24-03-14Allergy grows profits StockMarketWire
24-03-14Half Yearly ReportRNS

RSS feeds

  • Editorial news feed for LSE:AGY Editorial
  • Regulatory news feed for LSE:AGY Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account